Popular on Rezul
- Robert DeMaio, Phinge CEO to Speak at 30th IIPLA 2026 on Securing IP, User Data & Digital Sovereignty via Verified App-less Tech. Attend the Live Q&A! - 183
- JiT Home Buyers Expands Local Presence to 18 Real Estate Markets Across the United States - 157
- Buy Retatrutide Research Peptide: Why Reta Is Getting So Much Attention - 145
- Paula Josephine Sadler Releases "Imagine" on 24th Anniversary of Sobriety - 136
- The Refugee Archive Launches Campaign to Preserve 21 Female-Headed Household Oral Histories in Rebel-Controlled Goma - 135
- Sales Blueprint Architect Launches, Helping Sales Professionals, Business Owners, and Consultants Close More Business With AI - 113
- CasaPerks and CredHub Partner to Help the Multifamily Industry Strengthen Resident Activation Through Credit-Building Rewards - 106
- New Book, The KI of Marketing, Helps Small Businesses Grow Without Trying to Outspend Bigger Competitors
- PulteGroup expands Northeast Florida presence with Oakmere coming soon to Mandarin
- DuoKey launches the World's First Agentic Crypto Agility Platform
Similar on Rezul
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)
- Baird Medical Turns Global Expansion Into Tangible Growth: N A S D A Q: BDMD Posts 25% Revenue Surge as U.S. and International Markets Accelerate
- Sky Quarry Enters a Powerful New Chapter: Refinery Restart Emminent, Nevada Oil Initiative and Visibility Put (NAS DAQ: SKYQ) in the Spotlight
- 54 Million Contract. New Chapter as AI Cybersecurity Platform Expands, Margins Surge & Management Signals Confidence. Cycurion, Inc: (NAS DAQ: CYCU)
- 5X Gross Margin Improvement to Beat EPS Consensus; $54.6 Million 10-Year Contract Award Puts Cybersecurity Leader on Path to a $30 Million Run Rate
- FDA Path Clears, Manufacturing Ramps Up + $22.3 Million Strengthens the Balance Sheet; Inflection Point for NRx Pharmaceuticals (N A S D A Q: NRXP)
- 5.6 Million EUR in Q1 Project Awards for Integrated IoT Solutions / Data Analytics Subsidiary of Smart City Developer: Affluence (Stock Symbol: AFFU)
- Merger Advancement For Embodied AI Co in Robotic Systems Serving High Value Hospitality, Gaming & Real Estate Sectors: MBody AI Corp. (NAS DAQ: MBAI)
Accelerate Files Preliminary Prospectus For New Funds Including Canadas First Merger Arbitrage ETF
Rezul News/10444532
CALGARY, Alberta - Rezul -- with the Canadian securities regulators for its Accelerate Arbitrage Fund (the "Arbitrage Fund") and Accelerate Market Neutral Yield Fund ("Market Neutral Fund", and together with the Arbitrage Fund, the "Funds"), alternative exchange traded funds that have applied to trade on the Toronto Stock Exchange under the tickers ARB and YLD, respectively.
Listing of the units of the Funds is subject to receipt of conditional approval and fulfilling all of the requirements of the Toronto Stock Exchange.
"We are excited to announce the filing of the preliminary prospectus for Canada's first merger arbitrage ETF," said Julian Klymochko, Founder and CEO of Accelerate. "We look forward to continuing to offer innovative investment solutions to help institutional investors and advisors diversify their portfolios."
About Accelerate Financial Technologies Inc.
Accelerate is leading innovation in financial services as the pioneer of institutional-caliber hedge fund and private equity ETFs for investors seeking long-term performance. Accelerate was established by a team with a track record of successfully managing award-winning hedge funds and is disrupting the asset management industry by offering performance-oriented alternative investment strategies previously reserved for wealthy investors at a fee significantly lower than competitors.
More on Rezul News
Accelerate: Because Performance Matters. Find out more at www.AccelerateShares.com
A preliminary prospectus dated December 6, 2019 (the "Prospectus") containing important information relating to these securities has been filed with securities commissions or similar authorities in each of the provinces and territories of Canada. The Prospectus is still subject to completion or amendment. A copy of the preliminary prospectus is available on SEDAR (www.sedar.com). There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued. No securities regulatory authority has expressed an opinion about the units of the Funds and it is an offence to claim otherwise.
Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions "expect", "intend", "will" and similar expressions to the extent they relate to a Fund or Accelerate. The forward-looking statements are not historical facts but reflect Accelerate's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Although Accelerate believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein. Accelerate undertakes no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other such factors which affect this information, except as required by law.
More on Rezul News
For media and investor inquiries:
Contact Accelerate at 1-855-892-0740 (toll-free), info@acceleratefintech.com or
Contact Michael Lee Hing, COO, Accelerate, (403) 975-5294, mleehing@acceleratefintech.com
Listing of the units of the Funds is subject to receipt of conditional approval and fulfilling all of the requirements of the Toronto Stock Exchange.
"We are excited to announce the filing of the preliminary prospectus for Canada's first merger arbitrage ETF," said Julian Klymochko, Founder and CEO of Accelerate. "We look forward to continuing to offer innovative investment solutions to help institutional investors and advisors diversify their portfolios."
About Accelerate Financial Technologies Inc.
Accelerate is leading innovation in financial services as the pioneer of institutional-caliber hedge fund and private equity ETFs for investors seeking long-term performance. Accelerate was established by a team with a track record of successfully managing award-winning hedge funds and is disrupting the asset management industry by offering performance-oriented alternative investment strategies previously reserved for wealthy investors at a fee significantly lower than competitors.
More on Rezul News
- Mesa West Capital Originates $27 Million Loan for Seattle Apartment Acquisition
- Canadian Tint Expo 2027: Why Every Window Tinter Should Compete in Niagara Falls on April 3rd & 4th
- The Drywall Helper Introduces a Versatile Approach to Measuring and Supporting Drywall
- InvisoScreen™ Introduces a New Approach to Window Screening
- Mach One Reports Launches Voice-First Software That Builds Inspection Reports On Site
Accelerate: Because Performance Matters. Find out more at www.AccelerateShares.com
A preliminary prospectus dated December 6, 2019 (the "Prospectus") containing important information relating to these securities has been filed with securities commissions or similar authorities in each of the provinces and territories of Canada. The Prospectus is still subject to completion or amendment. A copy of the preliminary prospectus is available on SEDAR (www.sedar.com). There will not be any sale or any acceptance of an offer to buy the securities until a receipt for the final prospectus has been issued. No securities regulatory authority has expressed an opinion about the units of the Funds and it is an offence to claim otherwise.
Certain statements included in this news release constitute forward-looking statements, including, but not limited to, those identified by the expressions "expect", "intend", "will" and similar expressions to the extent they relate to a Fund or Accelerate. The forward-looking statements are not historical facts but reflect Accelerate's current expectations regarding future results or events. These forward-looking statements are subject to a number of risks and uncertainties that could cause actual results or events to differ materially from current expectations. Although Accelerate believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, readers are cautioned not to place undue reliance on such statements due to the inherent uncertainty therein. Accelerate undertakes no obligation to update publicly or otherwise revise any forward-looking statement or information whether as a result of new information, future events or other such factors which affect this information, except as required by law.
More on Rezul News
- Building a Diversified Healthcare Platform as Exosome Science, Telehealth, Diagnostics & Strategic Acquisitions Converge: NexTel Medical (OTCID: MAJI)
- Most Indiana Plane Crashes Happen Away from the State's Major Airports
- L2 Aviation Welcomes Jason Marshall as Vice President of Sales and Business Development
- Mom Era, Still That Girl: Family Art Tees 25% Off
- Fashion vs. Fascism - Because Democracy Should Always Be In Style
For media and investor inquiries:
Contact Accelerate at 1-855-892-0740 (toll-free), info@acceleratefintech.com or
Contact Michael Lee Hing, COO, Accelerate, (403) 975-5294, mleehing@acceleratefintech.com
Source: Accelerate Financial Technologies
0 Comments
Latest on Rezul News
- Cre8ive Realty Highlights Waterfront Property Expertise Across Southwest Florida
- Lawsuit Alleges American Deli Food Caused Severe Illness, Acute Kidney Failure, And Eight-day Hospitalization
- PRM Capital Offers Investment Property Financing for Lawton, Oklahoma Investors
- FBI/DoW plot uncovered to hurt Trump/Vance through encouraged "widespread" cybersecurity breaches and racketeering theft of $80m in USDA payments
- Bettingbladet releases H1 2026 report on the Swedish online gambling market
- Garage door installation or repair in Minnesota? Which makes more sense for your family?
- Treasure Coast, of Florida Fall 2026 Real Estate Update
- Stockdale Capital Partners and Hamilton Lane Acquire So Cal Shopping Center for $157 Mil
- Super Rooter Expands to 190 Plumbing, Sewer, and Drain Service Locations Across the United States
- European Patent for ALS Program Expands the Story: HOPE Deploys Robotic TMS & FDA Commercialization Path Advances: NRx Pharmaceuticals: NAS DAQ: NRXP
- VICTURY Sports Announces Formation of Youth Sports League Built on the Official, Patented, and Award-Winning Keepy Uppy® Ball
- Spencer Buys Houses Completes Renovation on Another Memphis Rental Property, Now Generating Income
- Congressman Chuck Edwards (NC-11) Presents ReadyCommunities Partnership 2026 National Service Award to Local Businessman / US Air Force Veteran
- Cress Creeks Farm Opens Fall Corn Maze and Baby Lamb Hayride Experience in Ellijay, Georgia
- Allstream Energy Partners Nominated in Multiple Categories for Fast Company's Best Workplaces for Innovators
- Downtown Sarasota Luxury Condo Sales Rise 39.8% Through August 2026 as Marketing Time Lengthens
- BIC Homes Offers Affordable Luxury New Homes in Northeast El Paso, TX
- Kerri Lawless Introduces New Home-Selling Option for Local Homeowners
- Indian Shores STR Condo Sales Rise 50% Year to Date as Median Price Falls 7% in 2026
- FDA-Cleared Zeta TMS Robotic System Moves Toward Deployment as FDA, DARPA and Commercial Catalysts Converge: NRx Pharmaceuticals (N A S D A Q: NRXP)